Albireo’s Bylvay approved in EU and US for rare paediatric liver disease
PFIC is a rare and progressive liver disease affecting young children which can lead to cirrhosis and liver failure
Read More
Tag: Bylvay
CHMP puts eight new medicines forward for EU approval
First one-time gene therapy for CALD among latest recommendations
Read More
- European life sciences coalition launched to boost investment ecosystem
- 99mtc‑maraciclatide granted fast track status for ILD imaging
- Bioxytran reports rapid viral clearance in phase 2 trial
- Thx Pharma and Biocodex sign rare disease licensing deal
- AstraZeneca bladder cancer therapy wins NICE backing
